Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year OnMarch 11, 2021 , the Board of Directors ofDicerna Pharmaceuticals, Inc. (the "Company") adopted the Company's Amended and Restated Bylaws (the "Restated Bylaws"). The Restated Bylaws amended and restated the Company's bylaws in their entirety to provide that, among other things, the district courts ofthe United States of America shall be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, unless the Company consents in writing to the selection of an alternative forum. The foregoing description of the Restated Bylaws is qualified in its entirety by reference to the Restated Bylaws, a copy of which is attached hereto as Exhibit 3.4 and is hereby incorporated by reference herein. Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 3.4 Amended and Restated Bylaws ofDicerna Pharmaceuticals, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source